Craneware plc Total Voting Rights (8323G)

TIDMCRW

RNS Number : 8323G

Craneware plc

31 March 2022

Craneware plc

("Craneware" or the "Company" or the "Group")

Total Voting Rights

As at 31 March 2022, the Company's issued share capital consisted of 35,542,169 ordinary shares of 1 pence each ("Ordinary Shares") all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as at 31 March 2022 is therefore 35,542,169.

The above figure (35,542,169 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.

For further information, please contact:

 
 
 Craneware plc                                                 [phone] 
 Keith Neilson, CEO 
 Craig Preston, CFO 
 
 
 Alma (Financial PR)                                           [phone] 
 Caroline Forde, Hilary Buchanan, Joe Pederzolli               [e-mail] 
 
 
 Peel Hunt (NOMAD and Joint Broker)                            [phone] 
 Dan Webster, Andrew Clark 
 
 
 Investec Bank PLC (Joint Broker)                              [phone] 
 Patrick Robb, Henry Reast, Sebastian Lawrence 
 
 Berenberg (Joint Broker )                                     [phone] 
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff 
 

About Craneware

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2,000 U.S hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRBKDBKPBKDONN

(END) Dow Jones Newswires

March 31, 2022 11:09 ET (15:09 GMT)